Shankhadip Nandi, Gargi Das, Khandekar Hussan Reza
email@example.com , firstname.lastname@example.org , email@example.com
Shankhadip Nandi1*, Gargi Das2, Khandekar Hussan Reza3
1Department of Pharmaceutics, Eminent College of Pharmaceutical Technology, Kolkata, West Bengal- 700126, India.
2Department of Pharmaceutics, Bengal School of Technology, Chinsurah, West Bengal- 712102, India.
3Department of Pharmaceutical Technology, Maulana Abul Kalam Azad University of Technology, West Bengal, India.
Volume - 15,
Issue - 11,
Year - 2022
Acute otitis media (AOM) is a common infection of early childhood with an inflammation of the middle ear and tympanic membrane. Azithromycin is a macrolide antibiotic which is proficient to provide effective treatment for pediatric AOM due to its in-vitro activity against the most common upper respiratory tract pathogens. The objective of this study was to develop and optimize orally disintegrating films (ODF) of azithromycin as an alternative patient compliant dosage form. Using casting method of films, five formulations (F1-F5) were fabricated and evaluated for different physico-chemical and mechanical parameters along with drug release kinetics. Design of Experiment approach was applied to discover the optimized ratio of the two disintegrants used in the formulations. FT-IR spectra confirmed the identity of azithromycin and absence of any chemical interaction between the drug and excipients. Optimized formulation was selected as F2 which comprised of two disintegrants i.e. crospovidone and croscarmellose sodium in 1:1 ratio. F2 possessed excellent physico-chemical, mechanical properties along with rapid dissolution. F2 demonstrated concentration dependent erosional type release pattern from a planer surface of hydrophilic matrix system. Addition of the disintegrating agents resulted in rapid fragmentation of the films following the above process. Accelerated stability study assured the longer shelf life of optimized ODFs. Rapid disintegration and dissolution may accelerate the onset of action bypassing hepatic first-pass metabolism which confirmed the utility of azithromycin loaded ODFs as alternative dosage form in management of pediatric AOM.
Cite this article:
Shankhadip Nandi, Gargi Das, Khandekar Hussan Reza. Formulation, evaluation and optimization of orally disintegrating films of Azithromycin using DOE approach for the pediatrics with acute otitis media. Research Journal of Pharmacy and Technology. 2022; 15(11):5031-7. doi: 10.52711/0974-360X.2022.00846
Shankhadip Nandi, Gargi Das, Khandekar Hussan Reza. Formulation, evaluation and optimization of orally disintegrating films of Azithromycin using DOE approach for the pediatrics with acute otitis media. Research Journal of Pharmacy and Technology. 2022; 15(11):5031-7. doi: 10.52711/0974-360X.2022.00846 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-11-31
1. Nunn T, Williams J. Formulation of medicines for children. Br J Clin Pharmacol. 2005;59(6):674-676. doi: 10.1111/j.1365-2125.2005.02410.x
2. Ivanovska V, Rademaker CMA, van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 2014;134(2):361-372. doi: 10.1542/peds.2013-3225
3. Geiling EMK, Cannon PR. Pathological effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA. 1938;111(10):919-926. doi: 10.1001/jama.1938.72790360005007
4. Maheswari KM, Devineni PK, Deekonda S, Shaik S, Uppala NP, Nalluri BN. Development and evaluation of mouth dissolving films of amlodipine besylate for enhanced therapeutic efficacy. J Pharm. 2014;2014:1-10. doi: 10.1155/2014/520949
5. Swamy SK, Arun G, Srinivas B, Goud BA. Effect of various super disintegrants on the drug release profile of orally disintegrating tablets. Asian J Pharm Tech. 2016;6(2):99-105. doi: https://doi.org/10.5958/2231-5713.2016.00014.3
6. Panigrahi R, Chowdary KA, Mishra G, Bhowmik M, Behera S. Formulation of fast dissolving tablets of lisinopril using combination of synthetic superdisintegrants. Asian J Pharm Tech. 2012;2(3):94-98.
7. Rao KS, Khan M, Udgirkar D, Patil PS, Biradar KV. Design and evaluation of meloxicam mouth dissolving tablets. Res J Pharm Dosage Form & Tech. 2015;7(1):44-50. doi: https://doi.org/10.5958/0975-4377.2015.00007.5
8. Panda BP, Dey NS, Rao MEB. Development of innovative orally fast disintegrating film dosage forms: a review. International Journal of Pharmaceutical Sciences and Nanotechnology. 2012;5(2):1666- 1674. doi: 10.37285/ijpsn.2012.5.2.2
9. Gondkar SB, Patil ND, Saudagar RB. Fast dissolving oral films. Asian J Pharm Res. 2016;6(1):56-58. doi: https://doi.org/10.5958/2231-5691.2016.00010.1
10. Block SL, Harrison CJ, Hedrick J, Tyler R, Smith A, Hedrick R. Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumonia. Int J Pediatr Otorhinolaryngol. 2001;61(1):47-60. doi: 10.1016/S0165-5876(01)00550-X
11. Arguedas A, Soley C, Kamicker BJ, Jorgensen DM. Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media. Int J Infect Dis. 2011;15(4):e240-e248. doi: 10.1016/j.ijid.2010.12.003
12. Arrieta A, Arguedas A, Fernandez P, Block SL, Emperanza P, Vargas SL, Erhardt WA, Caprariis PJ, Rothermel CD. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother. 2003;47(10):3179-3186. doi: 10.1128%2FAAC.47.10.3179-3186.2003
13. Yadav AV, Urade MN. Preparation and evaluation of chitosan containing mucoadhesive buccal films of venlafaxine hydrochloride. Research J Pharm and Tech. 2010;3(4):1213-1217.
14. Hoffmann EM, Breitenbach A, Breitkreutz J. Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv. 2011;8(3):299-316. doi: 10.1517/17425247.2011.553217
15. Nirmala D, Nandhini S, Sudhakar M. Design and evaluation of fast dissolving oral films of zolpidem by solvent casting method. Asian J Pharm Res. 2016;6(2):67-71. doi: https://doi.org/10.5958/2231-5691.2016.00012.5
16. Sanjay P, Gupta NV, Gowda DV, Sivadasu P. Formulation and evaluation of oral disintegrating film of atenolol. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(8):312-315. doi: 10.22159/ajpcr.2018.v11i8.26464
17. Kulkarni SV, Ranjit KP, Patel N, Ramesh B, Rao SB, Ashok KP. Development and evaluation of diltiazem hydrochloride transdermal patches by using glycerol and castor oil as plasticizers. Research J Pharm and Tech. 2010;3(3):905-909.
18. Sahu P, Anjali, Sahu GK, Sharma H, Kaur CD. Formulation, characterization and ex vivo evaluation of epinephrine transdermal patches. Research J Pharm and Tech. 2020;13(4):1684-1692. doi: https://doi.org/10.5958/0974-360X.2020.00305.4
19. Bhyan B, Jangra S, Kaur M, Sing H. Orally fast dissolving films: innovations in formulation and technology. Int J Pharm Sci Rev Res. 2011;9(2):50-57.
20. Nair RS, Ling TN, Shukkoor MSA, Manickam B. Matrix type transdermal patches of captopril: ex vivo permeation studies through excised rat skin. Journal of Pharmacy Research. 2013;6(7):774-779. doi: https://doi.org/10.1016/j.jopr.2013.07.003
21. Swati CJ, Asawaree AH, Bhanudas SK, Aniruddha RC. Development and evaluation of mucoadhesive buccal patches of nifedipine. Research J Pharm and Tech. 2011;4(6):944-948.
22. Raza SN, Kar AH, Wani TU, Khan NA. Formulation and evaluation of mouth dissolving films of losartan potassium using 32 factorial design. Int J Pharm Sci & Res. 2019;10(3):1402-1411.
23. Chakraborty P, Dey BK, Bahadur S, Thakkar S, Das S. Design, development, physicochemical and in vitro evaluation of transdermal patches containing verapamil hydrochloride in ethyl cellulose - povidone matrices. Research J Pharm and Tech. 2009;2(1):168-172.
24. Irfan M, Rabel S, Bukhtar Q, Qadir MI, Jabeen F, Khan A. Orally disintegrating films: a modern expansion in drug delivery system. Saudi Pharmaceutical Journal. 2016;24(5):537-546. doi: 10.1016/j.jsps.2015.02.024
25. Takeuchi Y, Umemura K, Tahara K, Takeuchi H. Formulation design of hydroxypropyl cellulose films for use as orally disintegrating dosage forms. Journal of Drug Delivery Science and Technology. 2018;46:93-100. doi: 10.1016/j.jddst.2018.05.002
26. Attimarad M, Venugopala KN, Aldhubaib BE, SreeHarsha N, Nair AB. Development of uv spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation. Plos One. 2019;14(9):1-15. doi: 10.1371/journal.pone.0222526
27. Zhan S, Wang J, Wang W, Cui L, Zhao Q. Preparation and in vitro release kinetics of nitrendipine-loaded PLLA–PEG–PLLA microparticles by supercritical solution impregnation process. RSC Adv. 2019;9(28):16167-16175. doi: 10.1039/C9RA01068H
28. Abdelbary A, Bendas ER, Ramadan AA, Mostafa DA. Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride. AAPS PharmSciTech. 2014;15(6): 1603-1610. doi: 10.1208/s12249-014-0186-8
29. Maddela S, Nalluri BN. Development of rizatriptan mouth dissolving films: a fast absorbing drug delivery system for effective treatment of migraine. Research J Pharm and Tech. 2019;12(6):2907-2916. doi: https://doi.org/10.5958/0974-360X.2019.00490.6
30. Hiremath P, Nuguru K, Agrahari V. Material attributes and their impact on wet granulation process performance. In Handbook of Pharmaceutical Wet Granulation, Edited by Narang AS and Badawy SIF. Academic Press, USA. 2019; 1st ed: pp. 263-315.